← Leaderboards
Jonathan D. Kurtis
Brown University
$16,800,696
Attributed
$16,800,696
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,290,969 · 15
By mechanism
R01$15,163,845 · 7
P20$2,607,121 · 4
R56$1,005,028 · 2
R21$359,599 · 1
R03$155,376 · 1
Top collaborators
- Jennifer F Friedman1 shared
Most similar at Brown University
Same institution · by research overlap
- Stephen T. McGarvey$18,190,958
- Karl T Kelsey$20,872,657
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortVaccinesAntigensParasitesResponseAntibodiesResistanceBaseAreaChildMorbidity - Disease RateVaccine DevelopmentFundingInfectionAdultScreeningProteomePlasmaVaccinationProductionFalciparum MalariaSchistosomiasisVaccine CandidateSchistosoma Japonicum
Grant awards (41)
Translational Approaches for Pathogens of Human Significance$2,490,273
P20 · FY2025 · GM
Identifying the targets of protective immunity to severe falciparum malaria$708,202
R01 · FY2025 · AI · contact PI
Identifying the targets of protective immunity to severe falciparum malaria$500,144
R56 · FY2023 · AI · contact PI
Tfh responses to novel vaccine candidates and protection from pediatric falciparum malaria$668,302
R01 · FY2021 · AI · contact PI
One Health Vaccine Development for Bovine and Human Schistosomiasis$431,339
R01 · FY2021 · HD · contact PI
One Health Vaccine Development for Bovine and Human Schistosomiasis$76,531
R01 · FY2021 · HD · contact PI
Tfh responses to novel vaccine candidates and protection from pediatric falciparum malaria$655,521
R01 · FY2020 · AI · contact PI
One Health Vaccine Development for Bovine and Human Schistosomiasis$452,259
R01 · FY2020 · HD · contact PI
One Health Vaccine Development for Bovine and Human Schistosomiasis$56,400
R01 · FY2020 · HD · contact PI
Tfh responses to novel vaccine candidates and protection from pediatric falciparum malaria$664,076
R01 · FY2019 · AI · contact PI
One Health Vaccine Development for Bovine and Human Schistosomiasis$458,360
R01 · FY2019 · HD · contact PI
PfSEA-1 based vaccines for falciparum malaria$759,349
R01 · FY2018 · AI · contact PI
Tfh responses to novel vaccine candidates and protection from pediatric falciparum malaria$672,534
R01 · FY2018 · AI · contact PI
One Health Vaccine Development for Bovine and Human Schistosomiasis$472,215
R01 · FY2018 · HD · contact PI
Tfh responses to novel vaccine candidates and protection from pediatric falciparum malaria$724,615
R01 · FY2017 · AI · contact PI
PfSEA-1 based vaccines for falciparum malaria$615,944
R01 · FY2017 · AI · contact PI
One Health Vaccine Development for Bovine and Human Schistosomiasis$509,898
R01 · FY2017 · HD · contact PI
PfSEA-1 based vaccines for falciparum malaria$441,295
R01 · FY2016 · AI · contact PI
Schistosome Vaccines$381,751
R01 · FY2016 · AI · contact PI
Schistosome Vaccines$558,938
R01 · FY2015 · AI · contact PI
PfSEA-1 based vaccines for falciparum malaria$441,454
R01 · FY2015 · AI · contact PI
PfSEA-1 based vaccines for falciparum malaria$442,090
R01 · FY2014 · AI · contact PI
Schistosome Vaccines$340,683
R01 · FY2014 · AI · contact PI
Schistosome Vaccines$353,180
R01 · FY2013 · AI · contact PI
Adjuvant and Dose Optimization of Paramyosin based Vaccines for Schistosmiasis$153,549
R21 · FY2013 · AI · contact PI
Adjuvant and Dose Optimization of Paramyosin based Vaccines for Schistosmiasis$206,050
R21 · FY2012 · AI · contact PI
Targeted Vaccine Development for Pediatric Falciparum Malaria$626,659
R01 · FY2011 · AI · contact PI
Vaccines for human Schistosomiasis japonica$504,884
R56 · FY2011 · AI · contact PI
Targeted Vaccine Development for Pediatric Falciparum Malaria$658,205
R01 · FY2010 · AI · contact PI
Targeted Vaccine Development for Pediatric Falciparum Malaria$611,777
R01 · FY2009 · AI · contact PI
Targeted Vaccine Development for Pediatric Falciparum Malaria$545,102
R01 · FY2008 · AI · contact PI
MECHANISMS OF SCHISTOSOME ASSOCIATED TROPHOBLAST INJURY$46,336
P20 · FY2008 · RR · contact PI
MECHANISMS OF SCHISTOSOME ASSOCIATED TROPHOBLAST INJURY$34,342
P20 · FY2007 · RR · contact PI
MECHANISMS OF TROPHOBLAST INJURY IN S JAPONICUM$36,170
P20 · FY2006 · RR · contact PI
Puberty, Immunity and Malnutrition in S. Japonicum$349,544
R01 · FY2005 · AI
Puberty, Immunity and Malnutrition in S. Japonicum$187,883
R01 · FY2005 · AI
Puberty, Immunity and Malnutrition in S. Japonicum$617,656
R01 · FY2004 · AI
Novel Vaccine Candidates for Falciparum Malaria$77,563
R03 · FY2004 · AI
Puberty, Immunity and Malnutrition in S. Japonicum$50,462
R01 · FY2004 · AI
Puberty, Immunity and Malnutrition in S. Japonicum$631,621
R01 · FY2003 · AI
Novel Vaccine Candidates for Falciparum Malaria$77,813
R03 · FY2003 · AI